StockData
Phathom Pharmaceuticals, Inc. logo

Phathom Pharmaceuticals, Inc. (PHAT) stock

PHATNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 29, 2026Score 4/30
$5.50−0.38 (-6.46%)

Close on Nov 17, 2026Market cap $447.10MP/E –Yield –

Phathom Pharmaceuticals market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Phathom Pharmaceuticals's market cap was $502.84M on Nov 11, 2026, against $1.11B a year earlier. Over the last 5 years it ranged from $273.53M to $1.18B, with a median of $554.79M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$502.84M-57.3%
2025Dec 31, 2025$1.18B+112.4%
2024Dec 31, 2024$554.79M+7.0%
2023Dec 29, 2023$518.67M+12.4%
2022Dec 30, 2022$461.63M-21.9%
2021Dec 31, 2021$591.03M-31.3%
2020Dec 31, 2020$860.93M+272.6%
2019Dec 31, 2019$231.09M–

More Phathom Pharmaceuticals figures

See a number that looks wrong?